8.31

1.31% -0.11

After Hours: 8.31

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $8.31, with a volume of 694.63K. It is down -1.31% in the last 24 hours and down -8.18% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$8.42

Open:

$8.33

24h Volume:

694.63K

Relative Volume:

0.31

Market Cap:

$1.17B

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

14.59

EPS:

0.5695

Net Cash Flow:

$60.67M

1W Performance:

+0.12%

1M Performance:

-8.18%

6M Performance:

-4.15%

1Y Performance:

-16.90%

1-Day Range:

$8.20

$8.47

1-Week Range:

$8.10

$8.60

52-Week Range:

$4.52

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2024-08-07

Latest SEC Filings

MRVI's Discussions on Twitter

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

03:32 AM

Monitoring Maravai LifeSciences Holdings Inc (MRVI) after recent insider movements - Knox Daily

03:32 AM

12:08 PM

Ready to Jump After Recent Trade: Maravai LifeSciences Holdings Inc (MRVI) - SETE News

12:08 PM

06:16 AM

Systematic Financial Management LP Reduces Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

06:16 AM

04:52 AM

Maravai LifeSciences' SWOT analysis: stock outlook amid mRNA transition By Investing.com - Investing.com UK

04:52 AM

Sep 29, 2024

Mackenzie Financial Corp Grows Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Sep 29, 2024

Sep 27, 2024

Point72 Asset Management L.P. Buys 2,109,199 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Sep 27, 2024

Sep 26, 2024